Erythropoietin prevents delayed hemodynamic dysfunction after subarachnoid hemorrhage in a randomized controlled experimental setting

Journal of the Neurological Sciences

Volumn 332, Issue 1-2, 2013, Pages 128-135

  Güresir, Erdem ^a   Vasiliadis, Nikos ^a   Konczalla, Jürgen ^a   Raab, Peter ^a   Hattingen, Elke ^a   Seifert, Volker ^a   Vatter, Hartmut ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Animal model; Delayed ischemic neurological deficit; Erythropoietin; Rat double hemorrhage model; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CISTERNA MAGNA; CONTROLLED STUDY; HEMODYNAMICS; MALE; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE;

ANIMAL MODEL; DELAYED ISCHEMIC NEUROLOGICAL DEFICIT; ERYTHROPOIETIN; RAT DOUBLE-HEMORRHAGE MODEL; SUBARACHNOID HEMORRHAGE; VASOSPASM;

ANALYSIS OF VARIANCE; ANIMALS; BASILAR ARTERY; BRAIN; CELL COUNT; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; HEMODYNAMICS; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; TIME FACTORS; VASOSPASM, INTRACRANIAL;

EID: 84881479794     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.07.004     Document Type: Article

References (59)

1. Velly L, Pellegrini L, Guillet B, Bruder N, Pisano P. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword? Pharmacol Ther Dec;128(3):445-59.
2. M. Brines, and A. Cerami Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response J Intern Med 264 5 Nov 2008 405 432
3. A.L. Siren, T. Fasshauer, C. Bartels, and H. Ehrenreich Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system Neurotherapeutics 6 1 Jan 2009 108 127
4. M. Spedding, and C. Spedding Drugs in sport: a scientist-athlete's perspective: from ambition to neurochemistry Br J Pharmacol 154 3 Jun 2008 496 501
5. J.R. Stubbs Alternatives to blood product transfusion in the critically ill: erythropoietin Crit Care Med 34 5 Suppl. May 2006 S160 S169
6. H.L. Corwin, A. Gettinger, T.C. Fabian, A. May, R.G. Pearl, and S. Heard Efficacy and safety of epoetin alfa in critically ill patients N Engl J Med 357 10 Sep 6 2007 965 976
7. M. Hasselblatt, H. Ehrenreich, and A.L. Siren The brain erythropoietin system and its potential for therapeutic exploitation in brain disease J Neurosurg Anesthesiol 18 2 Apr 2006 132 138
8. T. Rabie, and H.H. Marti Brain protection by erythropoietin: a manifold task Physiology (Bethesda) 23 Oct 2008 263 274
9. M.A. van der Kooij, F. Groenendaal, A. Kavelaars, C.J. Heijnen, and F. van Bel Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia Brain Res Rev 59 1 Nov 2008 22 33
10. Jerndal M, Forsberg K, Sena ES, Macleod MR, O'Collins VE, Linden T, et al. A systematic review and meta-analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metab May;30(5):961-8.
11. Bouzat P, Francony G, Thomas S, Valable S, Mauconduit F, Fevre MC, et al. Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative. Crit Care Med May 5.
12. C. Adembri, A. Massagrande, A. Tani, M. Miranda, M. Margheri, and R. De Gaudio Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury Crit Care Med 36 3 Mar 2008 975 978
13. G. Grasso Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage J Neurosurg Sci 45 1 Mar 2001 7 14
14. G. Grasso, M. Buemi, C. Alafaci, A. Sfacteria, M. Passalacqua, and A. Sturiale Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage Proc Natl Acad Sci U S A 99 8 Apr 16 2002 5627 5631
15. G. Chen, S. Zhang, J. Shi, J. Ai, and C. Hang Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage Cytokine 45 3 Mar 2009 162 168
16. Zhang J, Zhu Y, Zhou D, Wang Z, Chen G. Recombinant human erythropoietin (rhEPO) alleviates early brain injury following subarachnoid hemorrhage in rats: possible involvement of Nrf2-ARE pathway. Cytokine Dec;52(3):252-7.
17. A.M. Murphy, A. Xenocostas, P. Pakkiri, and T.Y. Lee Hemodynamic effects of recombinant human erythropoietin on the central nervous system after subarachnoid hemorrhage: reduction of microcirculatory impairment and functional deficits in a rabbit model J Neurosurg 109 6 Dec 2008 1155 1164
18. J.B. Springborg, X. Ma, P. Rochat, G.M. Knudsen, O. Amtorp, and O.B. Paulson A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats Br J Pharmacol 135 3 Feb 2002 823 829
19. Talving P, Lustenberger T, Kobayashi L, Inaba K, Barmparas G, Schnuriger B, et al. Erythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control study. Ann Surg Jan;251(1):1-4.
20. H. Ehrenreich, K. Weissenborn, H. Prange, D. Schneider, C. Weimar, and K. Wartenberg Recombinant human erythropoietin in the treatment of acute ischemic stroke Stroke 40 12 Dec 2009 e647 e656
21. H. Ehrenreich, M. Hasselblatt, C. Dembowski, L. Cepek, P. Lewczuk, and M. Stiefel Erythropoietin therapy for acute stroke is both safe and beneficial Mol Med 8 8 Aug 2002 495 505
22. M.Y. Tseng, P.J. Hutchinson, H.K. Richards, M. Czosnyka, J.D. Pickard, and W.N. Erber Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article J Neurosurg 111 1 Jul 2009 171 180
23. J.B. Springborg, C. Moller, P. Gideon, O.S. Jorgensen, M. Juhler, and N.V. Olsen Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial Acta Neurochir (Wien) 149 11 Nov 2007 1089 1101 [discussion 101]
24. J.B. Bederson, E.S. Connolly Jr., H.H. Batjer, R.G. Dacey, J.E. Dion, and M.N. Diringer Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association Stroke 40 3 Mar 2009 994 1025
25. Turner JD, Mammis A, Prestigiacomo CJ. Erythropoietin for the treatment of subarachnoid hemorrhage: a review. World Neurosurg May;73(5):500-7.
26. R.L. Macdonald Management of cerebral vasospasm Neurosurg Rev 29 3 Jul 2006 179 193
27. J. Cahill, J.W. Calvert, and J.H. Zhang Mechanisms of early brain injury after subarachnoid hemorrhage J Cereb Blood Flow Metab 26 11 Nov 2006 1341 1353
28. C.P. Nolan, and R.L. Macdonald Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm? Neurosurg Focus 21 3 2006 E1
29. R.L. Macdonald, N.F. Kassell, S. Mayer, D. Ruefenacht, P. Schmiedek, and S. Weidauer Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial Stroke 39 11 Nov 2008 3015 3021
30. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2), Lancet Neurol Jul;10(7):618-25.
31. Digicaylioglu M. Erythropoietin in stroke: quo vadis. Expert Opin Biol Ther Jun;10(6):937-49.
32. Macdonald RL. Erythropoietin: will it improve outcome after subarachnoid hemorrhage? World Neurosurg May;73(5):463-4.
33. H. Vatter, J. Konczalla, S. Weidauer, C. Preibisch, A. Raabe, and M. Zimmermann Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm Neurosurgery 60 6 Jun 2007 1100 1108 [discussion 8-9]
34. H. Vatter, S. Weidauer, J. Konczalla, E. Dettmann, M. Zimmermann, and A. Raabe Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model Neurosurgery 58 6 Jun 2006 1190 1197 [discussion-7]
35. Güresir E, Raabe A, Jaiimsin A, Dias S, Raab P, Seifert V, et al. Histological evidence of delayed ischemic brain tissue damage in the rat double-hemorrhage model. J Neurol Sci Jun 15;293(1-2):18-22.
36. A.L. Siren, M. Fratelli, M. Brines, C. Goemans, S. Casagrande, and P. Lewczuk Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress Proc Natl Acad Sci U S A 98 7 Mar 27 2001 4044 4049
37. M.L. Brines, P. Ghezzi, S. Keenan, D. Agnello, N.C. de Lanerolle, and C. Cerami Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc Natl Acad Sci U S A 97 19 Sep 12 2000 10526 10531
38. J.B. Bederson, L.H. Pitts, M. Tsuji, M.C. Nishimura, R.L. Davis, and H. Bartkowski Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination Stroke 17 3 May-Jun 1986 472 476
39. H.J. Wittsack, A. Ritzl, and U. Modder User friendly analysis of MR investigations of the cerebral perfusion: Windows(R)-based image processing Rofo 6 Jun 2002 742 746
40. M. Soehle, A. Heimann, and O. Kempski Postischemic application of lipid peroxidation inhibitor U-101033E reduces neuronal damage after global cerebral ischemia in rats Stroke 29 6 Jun 1998 1240 1246 [discussion 6-7]
41. Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med May;38(5):1284-90.
42. R.M. Pluta, J. Hansen-Schwartz, J. Dreier, P. Vajkoczy, R.L. Macdonald, and S. Nishizawa Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought Neurol Res 31 2 Mar 2009 151 158
43. Laskowitz DT, Kolls BJ. Neuroprotection in subarachnoid hemorrhage. Stroke Oct;41(10 Suppl):S79-84.
44. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med Apr;17(4):439-47.
45. Sehba FA, Pluta RM, Zhang JH. Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol Feb;43(1):27-40.
46. Vatter H, Guresir E, Berkefeld J, Beck J, Raabe A, du Mesnil de Rochemont R, et al. Perfusion-diffusion mismatch in MRI to indicate endovascular treatment of cerebral vasospasm after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry Aug;82(8):876-83.
47. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials. Neurocrit Care Dec;13(3):416-24.
48. Marbacher S, Fandino J, Kitchen ND. Standard intracranial in vivo animal models of delayed cerebral vasospasm. Br J Neurosurg Aug;24(4):415-34.
49. E. Titova, R.P. Ostrowski, J.H. Zhang, and J. Tang Experimental models of subarachnoid hemorrhage for studies of cerebral vasospasm Neurol Res 31 6 Jul 2009 568 581
50. G.J. del Zoppo Microvascular changes during cerebral ischemia and reperfusion Cerebrovasc Brain Metab Rev 6 1 Spring 1994 47 96
51. F.M. Faraci, and D.D. Heistad Regulation of large cerebral arteries and cerebral microvascular pressure Circ Res 66 1 Jan 1990 8 17
52. Immonen R, Heikkinen T, Tahtivaara L, Nurmi A, Stenius TK, Puolivali J, et al. Cerebral blood volume alterations in the perilesional areas in the rat brain after traumatic brain injury - comparison with behavioral outcome. J Cereb Blood Flow Metab Jul;30(7):1318-28.
53. Hayward NM, Tuunanen PI, Immonen R, Ndode-Ekane XE, Pitkanen A, Grohn O. Magnetic resonance imaging of regional hemodynamic and cerebrovascular recovery after lateral fluid-percussion brain injury in rats. J Cereb Blood Flow Metab Jan;31(1):166-77.
54. M. Wintermark, M. Sesay, E. Barbier, K. Borbely, W.P. Dillon, and J.D. Eastwood Comparative overview of brain perfusion imaging techniques Stroke 36 9 Sep 2005 e83 e99
55. G.M. Palmer, B.E. Cairns, S.L. Berkes, P.S. Dunning, G.A. Taylor, and C.B. Berde The effects of lidocaine and adrenergic agonists on rat sciatic nerve and skeletal muscle blood flow in vivo Anesth Analg 95 4 Oct 2002 1080 1086 [table of contents]
56. H. Vatter, S. Weidauer, S. Dias, C. Preibisch, S. Ngone, and A. Raabe Persistence of the nitric oxide-dependent vasodilator pathway of cerebral vessels after experimental subarachnoid hemorrhage Neurosurgery 60 1 Jan 2007 179 187 [discussion 87-8]
57. M. Saqqur, D. Zygun, and A. Demchuk Role of transcranial Doppler in neurocritical care Crit Care Med 35 5 Suppl May 2007 S216 S223
58. S.T. Lee, K. Chu, D.I. Sinn, K.H. Jung, E.H. Kim, and S.J. Kim Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage J Neurochem 96 6 Mar 2006 1728 1739
59. O. Verdonck, H. Lahrech, G. Francony, O. Carle, R. Farion, and Y. Van de Looij Erythropoietin protects from post-traumatic edema in the rat brain J Cereb Blood Flow Metab 27 7 Jul 2007 1369 1376